Mirum Pharmaceuticals Inc (MIRM)

Dec 18, 2024

State Street Corp Buys 297,511 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 18, 2024

Dec 17, 2024

Mirum Pharmaceuticals' SWOT analysis: liver disease specialist's stock poised for growth - Investing.com

Dec 17, 2024

Dec 17, 2024

Wellington Management Group LLP Has $4.77 Million Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 17, 2024

Dec 16, 2024

741,368 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by Lord Abbett & CO. LLC - MarketBeat

Dec 16, 2024

Dec 16, 2024

Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea - Marketscreener.com

Dec 16, 2024

Dec 15, 2024

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $57.73 - MarketBeat

Dec 15, 2024

Dec 12, 2024

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? - MSN

Dec 12, 2024

Dec 11, 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 10, 2024 - BioSpace

Dec 11, 2024

Dec 10, 2024

Frazier Life Sciences Management L.P. Purchases 75,000 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 10, 2024

Dec 10, 2024

Mirum Pharmaceuticals Awards Key Inducement Grants to Strengthen Leadership Team - StockTitan

Dec 10, 2024

Dec 09, 2024

Investors Aren't Buying Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Revenues - Simply Wall St

Dec 09, 2024

Dec 09, 2024

Charles Schwab Investment Management Inc. Acquires 17,149 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 09, 2024

Dec 06, 2024

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities - Yahoo Finance

Dec 06, 2024

Dec 05, 2024

(MIRM) Trading Advice - Stock Traders Daily

Dec 05, 2024

Dec 04, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Janus Henderson Group PLC - MarketBeat

Dec 04, 2024

Dec 02, 2024

Mirum Shares Surge More Than 90% in 6 Months: Here's Why - MSN

Dec 02, 2024

Dec 02, 2024

Erste Asset Management GmbH Buys Shares of 260,000 Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 02, 2024

Dec 02, 2024

Intech Investment Management LLC Takes Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Dec 02, 2024

Nov 30, 2024

Eventide Asset Management LLC Sells 1,119,457 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 30, 2024

Nov 27, 2024

Loomis Sayles & Co. L P Buys New Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 27, 2024

Nov 25, 2024

Connor Clark & Lunn Investment Management Ltd. Acquires 21,526 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 25, 2024

Nov 24, 2024

(MIRM) Technical Data - Stock Traders Daily

Nov 24, 2024

Nov 23, 2024

Mirum Pharmaceuticals success with study of drug for chronic liver disease - OutSourcing-Pharma.com

Nov 23, 2024

Nov 20, 2024

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised - MSN

Nov 20, 2024

Nov 20, 2024

Phocas Financial Corp. Cuts Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Nov 20, 2024

Nov 20, 2024

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $57.73 - MarketBeat

Nov 20, 2024

Nov 19, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Position Decreased by First Turn Management LLC - MarketBeat

Nov 19, 2024

Nov 18, 2024

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Down 4.6% After Insider Selling - MarketBeat

Nov 18, 2024

Nov 18, 2024

Cantor Fitzgerald Analysts Raise Earnings Estimates for MIRM - MarketBeat

Nov 18, 2024

Nov 16, 2024

Insider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells 2,500 Shares of Stock - MarketBeat

Nov 16, 2024

Nov 15, 2024

Mirum Pharmaceuticals SVP sells $117,752 in stock - Investing.com

Nov 15, 2024

Nov 15, 2024

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 15, 2024

Nov 15, 2024

Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results - Simply Wall St

Nov 15, 2024

Nov 15, 2024

HC Wainwright Has Positive Estimate for MIRM FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

Leerink Partnrs Has Bullish Outlook for MIRM FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 14, 2024

Mirum Pharmaceuticals Inc (MIRM) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Janus Henderson Group PLC's Strategic Adjustment in Mirum Pharma - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Eventide Asset Management's Strategic Reduction in Mirum Pharmac - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

HC Wainwright Issues Pessimistic Estimate for MIRM Earnings - MarketBeat

Nov 14, 2024

Nov 14, 2024

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting - Business Wire

Nov 14, 2024

Nov 14, 2024

Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Mirum shares target lifted on raised sales guidance and strong LIVMARLI sales - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

How To Trade (MIRM) - Stock Traders Daily

Nov 13, 2024

Nov 13, 2024

Breaking Down Mirum Pharmaceuticals: 5 Analysts Share Their Views - Benzinga

Nov 13, 2024

Nov 13, 2024

Mirum Pharmaceuticals (NASDAQ:MIRM) Issues Quarterly Earnings Results, Beats Estimates By $0.15 EPS - MarketBeat

Nov 13, 2024

Nov 13, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Robert W. Baird Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $50.00 - MarketBeat

Nov 13, 2024

Nov 13, 2024

Mirum Pharmaceuticals stock hits all-time high of $45.28 By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

Mirum Pharmaceuticals stock hits all-time high of $45.28 - Investing.com

Nov 13, 2024

Nov 12, 2024

Mirum Pharmaceuticals Reports Strong Q3 Sales Growth - TipRanks

Nov 12, 2024